Howard Berman - 31 Jan 2024 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
31 Jan 2024
Net transactions value
$0
Form type
4
Filing time
02 Feb 2024, 20:00:12 UTC
Previous filing
01 Mar 2023
Next filing
05 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +189,680 $0.000000 189,680 31 Jan 2024 Common Stock, par value $0.0001 per share 189,680 $5.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.